Premium
Stelazine‐induced pigmentation
Author(s) -
BUCKLEY C.,
THOMAS V.,
LEWIN J.,
HARRIS D.,
RUSTIN M.H.A.
Publication year - 1994
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/j.1365-2230.1994.tb01145.x
Subject(s) - melanosis , dermatology , medicine , pigmentation disorder , hyperpigmentation , sun exposure , melanoma , cancer research
Summary A case of a West Indian patient is reported who developed abnormal blue‐grey pigmentation on exposed areas of skin following treatment with low dose stelazine. Oculocutaneous melanosis is a well‐recognized side‐effect of prolonged phenothiazine treatment. In this condition the areas of skin exposed to sunlight develop a violaceous, blue‐grey or slate‐grey colour in more severe cases. These characteristic changes are rarely seen now. We describe the case of a patient who developed pigmentation while taking a low dose of stelazine for 5 years.